Evidence map›Paper›PMID 18366614›Full record

ArticleBMC genomics2008

Algorithms to estimate the lower bounds of recombination with or without recurrent mutations.

Xiaoming Liu, Yun-Xin Fu

Abstract readComparative Study
In one paragraph

Article in BMC genomics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaoming LiuHuman Genetics Center, School of Public Health, University of Texas at Houston, Houston, Texas 77030, USA. Xiaoming.Liu@uth.tmc.edu
Yun-Xin Fu

Funding

COALESCENT THEORY AND ANALYIS OF DNA POLYMORPHISMSR01GM050428 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FU, YUN-XIN · 2000 to 2003
$737k
Statistical Methods for Studying Infectious diseaseR01GM060777 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FU, YUN-XIN · 2001 to 2004
$385k
NIGMS NIH HHS 5R01 GM50428-09NIGMS NIH HHS 5R01 GM60777-04NIGMS NIH HHS R01 GM050428NIGMS NIH HHS R01 GM060777
6 · The paper itself

Abstract

backgroundAn important method to quantify the effects of recombination on populations is to estimate the minimum number of recombination events, Rmin, in the history of a DNA sample. People have focused on estimating the lower bound of Rmin, because it is also a valid lower bound for the true number of recombination events occurred. Current approaches for estimating the lower bound are under the assumption of the infinite site model and do not allow for recurrent mutations. However, recurrent mutations are relatively common in genes with high mutation rates or mutation hot-spots, such as those in the genomes of bacteria or viruses.

resultsIn this paper two new algorithms were proposed for estimating the lower bound of Rmin under the infinite site model. Their performances were compared to other bounds currently in use. The new lower bounds were further extended to allow for recurrent mutations. Application of these methods were demonstrated with two haplotype data sets.

conclusionsThese new algorithms would help to obtain a better estimation of the lower bound of Rmin under the infinite site model. After extension to allow for recurrent mutations, they can produce robust estimations with the existence of high mutation rate or mutation hot-spots. They can also be used to show different combinations of recurrent mutations and recombinations that can produce the same polymorphic pattern in the sample.

Indexed as

AlgorithmsModels, GeneticPolymorphism, GeneticHaplotypesMutationRecombination, Genetic

Identifiers

PMID18366614
PMCPMC2386066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.